194
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, spectral and antimicrobial studies of a novel macrocyclic ligand containing a piperazine moiety and its binuclear metal complexes

, , &
Pages 85-96 | Received 21 Sep 2005, Accepted 02 Dec 2005, Published online: 14 Feb 2007
 

Abstract

A novel macrocycle 1,16-diaza-7,10-diamino-6,11-dioxo-1,17-bis[2′-hydroxy-5′-aminobenzyl]-piperazine-4,12-cyclododecadiene, [H4L] has been synthesized by a multistep process. The interaction of 5-amino salicylic acid, piperazine and formaldehyde in ethanol gave PC-1, which was reduced into a chloro-derivative PC-2. PC-2 by reacting with ethylenediamine gave a new macrocyclic ligand titled [H4L]. Its binuclear complexes with Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) ions have also been synthesized. The ligand and all metal complexes have been characterized by elemental analysis, IR, 1H NMR, 13C NMR and U.V.Visible spectroscopy. Molar conductance and magnetic moment measurements have also been determined. Microanalytical data revealed 1 : 2 molar ratio of ligand to metal in all the complexes. The spectral and magnetic data indicate that Mn(II), Co(II), Ni(II) complexes show octahedral geometry with two water molecules while Cu(II) and Zn(II) complexes exhibit square planar and tetrahedral environments, respectively. The compounds show significant inhibitory activity against seven bacteria and seven fungi.

Acknowledgement

The authors wish to express their sincere thanks to “Third World Academy of Sciences, Italy” for U.V./Visible spectrophotometer EZ-201 (Perkin-Elmer) through research grant scheme no. 00-047RG/CHE/AS.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.